KR920007271B1 - 신규한 벤즈아미드의 제법 - Google Patents

신규한 벤즈아미드의 제법 Download PDF

Info

Publication number
KR920007271B1
KR920007271B1 KR1019860005407A KR860005407A KR920007271B1 KR 920007271 B1 KR920007271 B1 KR 920007271B1 KR 1019860005407 A KR1019860005407 A KR 1019860005407A KR 860005407 A KR860005407 A KR 860005407A KR 920007271 B1 KR920007271 B1 KR 920007271B1
Authority
KR
South Korea
Prior art keywords
yield
dried
washed
formula
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019860005407A
Other languages
English (en)
Korean (ko)
Other versions
KR870001172A (ko
Inventor
작겔린 프랑세스치니
레네 가르다익스-루세로
조셋트 마가릿
Original Assignee
쏘씨에떼 데뛰드 시앙띠훠끄 에 앵둬스트리엘 드 일-드-프랑스
알란 갈로차트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쏘씨에떼 데뛰드 시앙띠훠끄 에 앵둬스트리엘 드 일-드-프랑스, 알란 갈로차트 filed Critical 쏘씨에떼 데뛰드 시앙띠훠끄 에 앵둬스트리엘 드 일-드-프랑스
Publication of KR870001172A publication Critical patent/KR870001172A/ko
Application granted granted Critical
Publication of KR920007271B1 publication Critical patent/KR920007271B1/ko
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
KR1019860005407A 1985-07-04 1986-07-04 신규한 벤즈아미드의 제법 Expired KR920007271B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8510199A FR2584401B1 (fr) 1985-07-04 1985-07-04 Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
FR10199 1985-07-04
FR8510199 1985-07-04

Publications (2)

Publication Number Publication Date
KR870001172A KR870001172A (ko) 1987-03-11
KR920007271B1 true KR920007271B1 (ko) 1992-08-29

Family

ID=9320954

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860005407A Expired KR920007271B1 (ko) 1985-07-04 1986-07-04 신규한 벤즈아미드의 제법

Country Status (42)

Country Link
US (1) US4703055A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0210893B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS62103069A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR920007271B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1021441C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR241906A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE57181T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU582253B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE905018A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG45853A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (2) CA1276644C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH667873A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS274658B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD251554A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE3620215A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK316386A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EG (1) EG18057A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2000187A6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI86422C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2584401B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2178035B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR861714B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU198023B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE58577B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL79241A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN163430B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS1374B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1214686B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU86499A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA20725A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO166124C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ216704A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA08355A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (2) PH23435A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL147410B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT82853B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1605924A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TN (1) TNSN86099A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU44790B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA864874B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZM (1) ZM5086A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZW (1) ZW12286A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US5214189A (en) * 1992-06-15 1993-05-25 The United States Of America As Represented By The Secretary Of The Navy N-(2-hydroxyethyl nitrate)-2,4,6,-trinitrobenzamide
US7507727B2 (en) * 2003-04-07 2009-03-24 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs and methods of using thereof
EP1858850B1 (en) * 2005-03-14 2015-01-21 Janssen Pharmaceutica NV Process for the preparation of opioid modulators

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2376424A (en) * 1940-12-23 1945-05-22 Parke Davis & Co Biological product and process of obtaining same
GB1268259A (en) * 1969-11-18 1972-03-29 Beecham Group Ltd Imidazoline derivatives
AT311338B (de) * 1971-03-08 1973-11-12 Malesci Sas Verfahren zum Herstellen eines neuen Imidazolinderivates und seiner Salze
CA1008856A (en) * 1971-11-15 1977-04-19 Ciba-Geigy Ag Triazolo-benzodiazepines
US3885040A (en) * 1973-02-28 1975-05-20 Univ Toledo Methods and benzamide compositions for producing hypotensive activity
GB1513631A (en) * 1976-02-17 1978-06-07 Gallardo Antonio Sa Piperidine derivatives
US4173464A (en) * 1976-05-07 1979-11-06 Sumitomo Chemical Company, Limited m-Phenoxybenzamide derivatives
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Also Published As

Publication number Publication date
DD251554A5 (de) 1987-11-18
MA20725A1 (fr) 1987-04-01
IL79241A (en) 1990-04-29
GB8616287D0 (en) 1986-08-13
IS1374B6 (is) 1989-06-30
FR2584401B1 (fr) 1987-11-20
IN163430B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-09-17
PT82853B (pt) 1988-04-21
FI86422B (fi) 1992-05-15
FI862793A0 (fi) 1986-07-01
NO166124C (no) 1991-06-12
CA1276644C (fr) 1990-11-20
EG18057A (en) 1991-08-30
CS504086A2 (en) 1990-09-12
GB2178035A (en) 1987-02-04
CN1021441C (zh) 1993-06-30
KR870001172A (ko) 1987-03-11
IS3116A7 (is) 1987-01-05
YU115086A (en) 1988-02-29
ATE57181T1 (de) 1990-10-15
IE861796L (en) 1987-01-04
NO862676L (no) 1987-01-05
PT82853A (fr) 1986-07-01
AR241906A1 (es) 1993-01-29
GR861714B (en) 1986-11-04
PL147410B1 (en) 1989-05-31
NZ216704A (en) 1990-03-27
DE3620215A1 (de) 1987-01-08
NO862676D0 (no) 1986-07-02
ES2000187A6 (es) 1988-01-01
HUT42451A (en) 1987-07-28
YU44790B (en) 1991-02-28
EP0210893B1 (fr) 1990-10-03
US4703055A (en) 1987-10-27
DK316386A (da) 1987-01-05
FI86422C (fi) 1992-08-25
PH23435A (en) 1989-08-07
AU582253B2 (en) 1989-03-16
CH667873A5 (fr) 1988-11-15
OA08355A (fr) 1988-02-29
EP0210893A1 (fr) 1987-02-04
PH25219A (en) 1991-03-27
NO166124B (no) 1991-02-25
FR2584401A1 (fr) 1987-01-09
JPH0586942B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-12-14
GB2178035B (en) 1989-02-08
JPS62103069A (ja) 1987-05-13
DK316386D0 (da) 1986-07-03
IT8648189A0 (it) 1986-06-27
FI862793L (fi) 1987-01-05
DK204891D0 (da) 1991-12-20
DK204891A (da) 1991-12-20
ZA864874B (en) 1987-02-25
ZM5086A1 (en) 1986-11-28
BE905018A (fr) 1987-01-02
AU5977986A (en) 1987-01-08
TNSN86099A1 (fr) 1990-01-01
IE58577B1 (en) 1993-10-06
ZW12286A1 (en) 1986-11-05
CS274658B2 (en) 1991-09-15
BG45853A3 (bg) 1989-08-15
DE3674667D1 (de) 1990-11-08
CA1300162C (fr) 1992-05-05
IL79241A0 (en) 1986-09-30
HU198023B (en) 1989-07-28
IT1214686B (it) 1990-01-18
CN86105682A (zh) 1987-02-04
LU86499A1 (fr) 1986-12-02
SU1605924A3 (ru) 1990-11-07

Similar Documents

Publication Publication Date Title
AT396685B (de) Verfahren zur herstellung von neuen 1,4-disubstituierten piperazinderivaten
DE69411317T2 (de) Indoloylguanidinderivate als Inhibitoren des Natrium-Protonen Austauschs
HU211680A9 (en) Pyrazolopyridine compounds which have useful pharmaceutical utility
PL117195B1 (en) Method of manufacture of novel derivatives of pyrrolidinyl-or pyrrolidinylalkylbenzamidepirolidinilalkilbenzamida
KR920007271B1 (ko) 신규한 벤즈아미드의 제법
FR2862971A1 (fr) Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
IE44792B1 (en) Heterocyclic derivatives of guanidine
DE69702419T2 (de) Substituierte Guanidin Derivate und ihre Verwendung als Na+/H+ Austausch Inhibitoren
FI64145B (fi) Foerfarande foer framstaellning av 2-arylamino-2-imidazolinderivat
KR930004653B1 (ko) 신규의 벤즈아미드 및 그것의 제법
KR20150100923A (ko) 신남산 아미드 유도체
US3072648A (en) X-phenyl-s
NO124430B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
Sato et al. Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity
KR910010081B1 (ko) 니트로아포빈카민산 유도체의 제조방법
US3743647A (en) Nicotinoylaminoethanesulfonylamino-thiazole and pharmaceutically acceptable acid addition salts thereof
DE1293751B (de) Zimtsaeureanilide und Verfahren zu ihrer Herstellung
TW498073B (en) 5-naphthalen-1-yl-1,3-dioxane derivatives, their preparation and their therapeutic application
JPS62178585A (ja) 1−〔3−(2−ヒドロキシ−3−アルキルアミノプロポキシ)−2−チエニル〕−3−フエニル−1−プロパノン及びそれらの酸付加塩並びにそれらの製造法及びそれらを含む薬学的組成物
CS225004B1 (en) The production of the derivate of 3-amine-delta raised to the square-pyrasoline
US1998101A (en) Ohxch
US20020082421A1 (en) Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide
JPH0576471B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO1992013842A1 (en) Sulfonamidopyridine compound
JP2003507463A (ja) 置換ピペラジン誘導体、その調製及びその薬物としての使用

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 19960712

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19970830

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19970830